Der Stabilisator (auch fürs Depot?)
MONMOUTH JUNCTION, N.J., March 24, 2015 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ CM: CTSO), a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to treat critically-ill and cardiac surgery patients in multiple countries worldwide, will report fiscal 2014 financial results after the market close on Tuesday, March 31, 2015.
CytoSorbents' management will host a live conference call and presentation webcast that will recount both operational and financial progress during Q4 2014 and fiscal year ending December 31, 2014, and answer pre-submitted questions as time permits.
http://finance.yahoo.com/news/...fiscal-2014-operating-110000422.html
Ein schwaches 4. Quartal aufgrund Problemen im Direktvertrieb und einer daraus resultierenden Restrukturierung schickt den Kurs allerdings in den Keller
Ich habe jedenfalls gerade meine Position verdoppelt.
